A single patient study revealed progressive amplifications of HGF, MET and EGFR in a patient with MPNST harboring early NF1 and TP53 loss, using longitudinal genomic analysis from pNF, to MPNST, to metastatic recurrence. Here, EGFR is linked to malignant peripheral nerve sheath tumor.